| abstract |
The 2,5-substituted benzenesulfonylureas and the thioureas of the formula I act as inhibitors of ATP-sensitive potassium channels and are useful in the treatment of cardiovascular diseases, in particular for the treatment of arrhythmias, the prevention of sudden cardiac death, or affecting reduced cardiac arrest. Also described are methods of preparing compounds of Formula I, their use, and pharmaceutical compositions containing such compounds. |